
The National Pharmaceutical Pricing Authority (NPPA) has ordered strict monitoring of lower prices on 137 non-scheduled anti-cancer drugs, so that the benefit of the cut reaches patients.
The revised prices come from Trade Margin Rationalisation (TMR), notified in a Gazette Order dated 17 October 2026, and have applied since 9 November 2026. The latest price lists, based on company submissions received up to 11 November, are on the NPPA website and the Pharma Sahi Daam app and portal.
Who must comply
Manufacturers, retailers, dealers, stockists, hospitals and medical institutions have been told to follow the revised prices and to display the updated price lists prominently at their premises and on their websites.
State Drug Controllers have been asked to monitor compliance closely. Violations may attract overcharging proceedings under the Drugs (Prices Control) Order, 2013. The controllers must send their Action Taken Reports to the NPPA by 16 November 2026.
How to complain
Patients can report overcharging, shortages or non-availability of medicines through the Pharma Sahi Daam app or portal, the NPPA helpline on 1800-111-255, or by email to monitoring-nppa@gov.in.
Source: official release by the Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals, issued through the Press Information Bureau, Government of India (13 NOV 2026 12:35PM by PIB Delhi). Read the full official text: NPPA Directs Strict Monitoring of Implementation of TMR on 137 Anti-Cancer Drugs.
How we verified this
VerifiedEvery fact, figure and quotation is taken from the official PIB release (Release ID 2335722) issued by the Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals on 13 NOV 2026 12:35PM by PIB Delhi; checked against the source on publication. Story written by BDT from that release; no outside facts added.
Sources
- 1.NPPA Directs Strict Monitoring of Implementation of TMR on 137 Anti-Cancer Drugs — Press Information Bureau, Government of India



